NCT03745807View on ClinicalTrials.gov

An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
Advanced Cancer
Interventions
BIOLOGICAL

NKTR-214

Specified dose on specified days

BIOLOGICAL

Nivolumab

Specified dose on specified days

Trial Locations (1)

1040045

Local Institution, Chuo-ku

Sponsors
All Listed Sponsors
collaborator

Nektar Therapeutics

INDUSTRY

collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY